Annals of Surgical Oncology

, Volume 3, Issue 3, pp 261–269 | Cite as

Chest wall invasive non-small cell lung cancer: Patterns of failure and implications for a revised staging system

  • David H. HarpoleJr.
  • Elizabeth A. Healey
  • Malcolm M. DeCampJr.
  • Steven J. Mentzer
  • Gary M. Strauss
  • David J. Sugarbaker
Original Articles

Abstract

Background: To assess outcomes and patterns of failure for chest wall invasive non-small cell lung cancer (T3 or IIIA NSCLC), data were acquired prospectively on 47 consecutive patients at a single institution over 6 years.

Methods: Preresectional stagings included bone scan, head and chest/abdominal computed tomography, and mediastinoscopy. There were 25 superior sulcus tumors (radiation and/or chemotherapy followed by resection) and 22 other chest wall invasive NSCLCs (resection alone).

Results: There were no perioperative deaths. Seventeen patients (36%) had an operative complication (median length of stay increased from 7 to 12 days; p<0.05). A complete pathologic resection was achieved for 44 of 47 patients (94%). The median survival was 38 months (actuarial 2- and 5-year survival rates of 62% and 50%, respectively). Median lengths of survival for superior sulcus and other chest wall tumors were 36 and >60 months, respectively. Significant univariate predictors of decreased overall and cancer-free survival were poor performance status, positive margins, and positive lymph nodes. Recurrence was observed in 22 of 47 patients (46%) at a median of 8 months (range 2–24); patterns of failure were in the ipsilateral chest (n=2; 4%) and at a distant site (n=15; 32%) or both (n=5; 11%).

Conclusions: The operative risk for chest wall invasive NSCLC is acceptable, even after neoadjuvant therapy, allowing for a 94% complete resection rate. The survival of this subset of stage IIIA patients may warrant a reappraisal of the international staging system.

Key Words

Chest wall resection Non-small cell lung cancer Superior sulcus tumors Pancoast tumors 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pancoast HK. Importance of careful roentgenray investigations of apical chest tumors.JAMA 1924;83:1407–11.Google Scholar
  2. 2.
    Pancoast H. Superior pulmonary sulcus tumor: tumor characterized by pain, Horner's syndrome, destruction of bone and atrophy of hand muscles.JAMA 1932;99:1391–6.Google Scholar
  3. 3.
    Charcack WM, MacCallum JD. Pancoast tumor: five-year survival without recurrence or metastases following radical resection and irradiation.J Thorac Surg 1956;31:535–42.Google Scholar
  4. 4.
    Shaw RR, Paulson DL, Kee JL Jr. Treatment of the superior sulcus tumor by irradiation followed by resection.Ann Surg 1961;154:29–40.Google Scholar
  5. 5.
    Mountain CF. A new international staging system for lung cancer.Chest 1986;89(suppl):225–33.Google Scholar
  6. 6.
    Heelan RT, Demas BE, Caravelli JF, et al. Superior sulcus tumors: CT and MR imaging.Radiology 1989;170:637–41.PubMedGoogle Scholar
  7. 7.
    Paulson DL. Carcinomas in the superior pulmonary sulcus.J Thorac Cardiovasc Surg 1975;70:1095–104.PubMedGoogle Scholar
  8. 8.
    Stanford W, Barnes RP, Tucker AR. Influence of staging in superior sulcus (Pancoast) tumors of the lung.Ann Thorac Surg 1980;29:406–9.PubMedGoogle Scholar
  9. 9.
    Miller JI, Mansour KA, Hatcher CR Jr. Carcinoma of the superior pulmonary sulcus.Ann Thorac Surg 1979;28:44–7.PubMedGoogle Scholar
  10. 10.
    Attar S, Miller JE, Satterfield J, et al. Pancoast's tumor: irradiation or surgery?Ann Thorac Surg 1979;28:578–86.PubMedGoogle Scholar
  11. 11.
    Mountain CF. Expanded possibilities for surgical treatment of lung cancer. Survival in stage IIIa disease.Chest 1990;97:1045–51.PubMedGoogle Scholar
  12. 12.
    Ginsberg RJ, Martini N, Armstrong JG, et al. Influence of surgical resection and brachytherapy on superior sulcus tumor. Abstract presented at the 30th annual meeting of the Society of Thoracic Surgeons, 1994.Google Scholar
  13. 13.
    Wright CD, Moncure AC, Shepard JA, Wilkins EW Jr, Mathisen DJ, Grillo HC. Superior sulcus lung tumors. Results of combined treatment (irradiation and radical resection).J Thorac Cardiovasc Surg 1987;94:69–74.PubMedGoogle Scholar
  14. 14.
    Anderson TM, Moy PM, Holmes EC. Factors affecting survival in superior sulcus tumors.J Clin Oncol 1986;4:1598–603.PubMedGoogle Scholar
  15. 15.
    Neal CR, Amdur RJ, Mendenhall WM, Kanuf DG, Block AJ, Million RR. Pancoast tumor: radiation therapy alone versus preoperative radiation therapy and surgery.Int J Radiat Oncol Biol Phys 1991;21:651–60.PubMedGoogle Scholar
  16. 16.
    Ricci C, Rendina EA, Venuta F, et al. Superior pulmonary sulcus tumors: radical resection and palliative treatment.Int Surg 1989;74:175–9.PubMedGoogle Scholar
  17. 17.
    Sartori F, Rea F, Calabro F, Mazzucco C, Bortolotti L, Tomio L. Carcinoma of the superior pulmonary sulcus. Results of irradiation and radical resection.J Thorac Cardiovasc Surg 1992;104:679–83.PubMedGoogle Scholar
  18. 18.
    Dartevelle PG, Chapelier AR, Macchiarini P, et al. Anterior transcervical-thoracic approach for radical resection of lung tumors invading the thoracic inlet.J Thorac Cardiovasc Surg 1993;105:1025–34.PubMedGoogle Scholar
  19. 19.
    Piehler JM, Pairolero PC, Weiland LH, Offord KP, Payne WS, Bernatz PE. Bronchogenic carcinoma with chest wall invasion: factors affecting survival following en bloc resection.Ann Thorac Surg 1982;34:684–91.PubMedGoogle Scholar
  20. 20.
    McCaughan BC, Martini N, Bains MS, McCormack PM. Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications.J Thorac Cardiovasc Surg 1985;89:836–41.PubMedGoogle Scholar
  21. 21.
    Albertucci M, DeMeester TR, Rothberg M, Hagen JA, Santoscoy R, Smyrk TC. Surgery and the management of peripheral lung tumors adherent to the parietal pleura.J Thorac Cardiovasc Surg 1992;103:8–12.PubMedGoogle Scholar
  22. 22.
    Mishina H, Suemasu K, Yoneyama T, et al. Surgical pathology and prognosis of the combined resection of chest wall and lung in lung cancer.Jpn J Clin Oncol 1978;8:161–8.Google Scholar
  23. 23.
    Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer.N Engl J Med 1990;323:940–5.PubMedGoogle Scholar
  24. 24.
    Merlier M, Rojas-Miranda A, Silbert D, Ranson-Bitker B. The staging issue: unification of criteria. In: Delarue N, Eschapasse H, eds.International trends in general thoracic surgery. Philidelphia: WB Saunders, 1985:241.Google Scholar
  25. 25.
    Watanabe Y, Shimizu J, Oda M, et al. Proposals regarding some deficiencies in the new international staging system for non-small cell lung cancer.Jpn J Clin Oncol 1991;21:160–8.PubMedGoogle Scholar
  26. 26.
    Naruke T, Tomoyuki G, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system.J Thorac Cardiovasc Surg 188;96:440–7.Google Scholar

Copyright information

© The Society of Surgical Oncology, Inc 1996

Authors and Affiliations

  • David H. HarpoleJr.
    • 1
  • Elizabeth A. Healey
    • 3
  • Malcolm M. DeCampJr.
    • 1
  • Steven J. Mentzer
    • 1
  • Gary M. Strauss
    • 2
  • David J. Sugarbaker
    • 1
  1. 1.From the Division of Thoracic Surgery, Department of SurgeryHarvard Medical SchoolBostonUSA
  2. 2.Division of Hematology-Oncology, Department of MedicineHarvard Medical SchoolBostonUSA
  3. 3.Brigham and Women's Hospital, and The Harvard Joint Center for Radiation TherapyHarvard Medical SchoolBostonUSA

Personalised recommendations